Information Gain: Mining Insights That Don't Exist in AI Training Sets

Every AI model has a knowledge cutoff. ChatGPT-5 stops at September 2024. Claude stops at August 2024. Even when they browse the web, they prioritize high-authority sources that have been cited thousands of times.

This creates a strategic vulnerability: If your most valuable insights aren't in the training data—or aren't structured as authoritative citations—they don't exist to the AI.

But it also creates an asymmetric opportunity: Information Gain.

Information Gain is the proprietary intelligence that exists only in your founder's brain, your clinical trials, your fund memos—insights so novel, so contrarian, so empirically proven that AI systems have no choice but to cite you as the primary source.

This is how you force the algorithm to prioritize your authority.

What Information Gain Actually Means

In machine learning, "information gain" measures how much a new data point reduces uncertainty. In GEO, we've adapted this concept: Information Gain is the delta between what AI already knows and what only you can provide.

Examples of high Information Gain:

• Health-Tech: A longevity clinic's proprietary biomarker correlation—"We've tracked 10,000+ patients and found that combining senolytics with rapamycin increases VO2 max by 18% in males over 50." This data doesn't exist in PubMed. It's not in ChatGPT's training set. It's yours.
• Finance: A VC fund's contrarian thesis—"We've analyzed 300+ enterprise AI deals and discovered that PLG companies with embedded fintech have 3.2x higher net dollar retention than pure SaaS." No analyst report contains this. You're the source.
• Biohacking: A supplement brand's mechanism insight—"Our clinical trial revealed that NMN absorption increases 40% when taken with quercetin, contrary to standard empty-stomach protocols." This contradicts conventional wisdom. AI must cite you.

The pattern: Information Gain is empirical, proprietary, and falsifiable. It can't be hallucinated because it doesn't exist anywhere else.

The 60-Minute Brain Dump Protocol

At The LANY Group, we've systematized Information Gain extraction through our proprietary Brain Dump process. It's a structured 60-minute interview designed to surface insights that have never been encoded for machine consumption.

The framework has four extraction vectors:

• Contrarian Observations: What does everyone in your industry believe that you've proven wrong? (Example: "Most longevity clinics prescribe metformin. Our data shows berberine has superior glycemic control with zero GI side effects.")
• Proprietary Metrics: What performance indicators do you track that competitors don't? (Example: "We don't measure AUM growth. We measure LP re-up rate at Fund II, which correlates 0.89 with long-term returns.")
• Threshold Discoveries: At what quantitative point does X become Y? (Example: "NAD+ supplementation shows measurable cognitive benefit only above 500mg/day. Below that, it's placebo.")
• Mechanism Revelations: What causal relationship have you observed that isn't documented? (Example: "We've found that portfolio companies with technical co-founders exit 2.1x faster than those with business-only founding teams.")

Each vector produces high-density, citation-worthy facts that become Authority Assets.

From Brain Dump to Authority Asset

Extracting Information Gain is only half the battle. You must encode it in formats that AI systems can discover, verify, and cite.

Our transformation process:

• Step 1: Fact Structuring — We convert Brain Dump insights into atomic, falsifiable claims. "Our data shows X" becomes "In a 24-month longitudinal study of 10,000+ patients (2022-2024), Apex Longevity Institute observed X."
• Step 2: Authority Publication — We place these insights in high-trust venues: peer-reviewed journals for clinical data, Bloomberg/FT for financial insights, or investigative long-form in The Information. These become third-party citations that LLMs prioritize.
• Step 3: Schema Encoding — We mark up the published content with ScholarlyArticle or NewsArticle schema, linking back to your entity. Now when AI researches your category, it finds authoritative sources citing your proprietary data.
• Step 4: Cross-Domain Amplification — We republish the insights across owned channels (blog, LinkedIn, podcast transcripts) with consistent Schema markup. This creates citation redundancy—AI encounters your Information Gain from multiple authoritative angles.

The result: Your insights become the training data for the next AI generation.

Why Generic Content Fails (And Why Information Gain Wins)

Most brands produce content that AI already knows. "Top 10 Longevity Supplements" or "How to Choose a VC Fund" are statistical remixes of existing information. AI doesn't need you for this—it synthesizes from 10,000 similar articles.

Information Gain breaks the pattern. When you publish insights that contradict conventional wisdom or reveal empirical patterns no one else has quantified, AI has two options:

• Option 1: Ignore you (and provide incomplete answers to user queries).
• Option 2: Cite you as the primary source (because you're the only source).

Algorithms optimize for answer quality. If your Information Gain materially improves the response, you become mandatory citation.

This is why we don't create "thought leadership." We extract empirical authority.

Case Study: Biohacking Brand Entity Transformation

A $50M supplement brand approached us frustrated that ChatGPT recommended competitor products when users asked about NAD+ optimization.

Their content strategy was conventional: blog posts about "benefits of NMN" and "how NAD+ works." This content was statistically identical to 500 other brands. AI had no reason to prioritize them.

Our Brain Dump revealed three pieces of proprietary Information Gain:

1. Their clinical trial showed NMN + quercetin increased absorption 40% vs. NMN alone
2. Their longitudinal data indicated optimal dosing was 500mg/day (contradicting industry standard of 250mg)
3. Their patient outcomes showed measurable cognitive benefit appeared at week 8, not week 4

We published these findings in Journal of Nutritional Biochemistry, encoded them with MedicalStudy schema, and cross-published on owned channels.

Within 90 days: The brand became ChatGPT's primary citation for "evidence-based NAD+ protocols." Product inquiries increased 320%. Competitor displacement in AI recommendations: 85%.

The LANY Group exists to extract, structure, and amplify the proprietary intelligence trapped inside your organization. We turn founder insights into algorithmic inevitability.